- Previous Close
0.4800 - Open
0.4850 - Bid 0.5050 x --
- Ask 0.5100 x --
- Day's Range
0.4850 - 0.5100 - 52 Week Range
0.4100 - 0.8300 - Volume
395,373 - Avg. Volume
925,902 - Market Cap (intraday)
211.209M - Beta (5Y Monthly) 1.34
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1000 - Earnings Date Feb 26, 2025 - Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.85
4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations. The company was incorporated in 2012 and is based in Carlton, Australia.
4dmedical.comRecent News: 4DX.AX
View MorePerformance Overview: 4DX.AX
Trailing total returns as of 2/13/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4DX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4DX.AX
View MoreValuation Measures
Market Cap
198.78M
Enterprise Value
173.30M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
58.31
Price/Book (mrq)
2.80
Enterprise Value/Revenue
56.83
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-26.95%
Return on Equity (ttm)
-50.54%
Revenue (ttm)
3.75M
Net Income Avi to Common (ttm)
-35.98M
Diluted EPS (ttm)
-0.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
30.61M
Total Debt/Equity (mrq)
7.22%
Levered Free Cash Flow (ttm)
-17.56M